Biotech Investing, Healthcare Stocks, FDA Calendar

Featured Content Medivation’s Xtandi Threatened by J&J’s New Acquisition One of the biotech laggards of the year, Medivation (NASDAQ: MDVN) saw a very high volume selloff (-6.78% ▼$47.41/share) yesterday after rival Johnson & Johnson (NYSE: JNJ) announced the acquisition of Aragon Pharmaceuticals – a company that was developing a Phase II metastatic castration-resistant prostate cancer (mCRPC) drug that the market considers a threat to Xtandi - Medivation’s lone pipeline drug. » Read More Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called aerobic respiration, which generates a usable form of energy. Glycolysis is the beginning of this process, which oxidizes glucose to form CO2, H20, and adenosine triphosphate (ATP). » Read More Short Sellers Flee Questcor on Sentiment Reversal Questcor Pharmaceuticals (NASDAQ: QCOR) was one of the most heavily shorted stocks on the NASDAQ according to the most recent data set from May 31st 2013, with 22.15 M shares short out of a float of 53.6 M share (41%). » Read More Subscriber Only Content » Read More Date: 6th May 2013 Carving out a Distinct Niche This research article is being releases to our premium subcribers first. » Read More Date: 20th February 2013 Watch this one closely, It could rise more quickly than expected. We are alerting our premium subscribers first on the potential for a nice upside trade potantial of ... » Read More Date: 5th February 2013 Things May Get Interesting Here This information is posted for our premium subscribers first.	Sector News ACADIA Issues Multiple Presentations of Data from Trial of Pimavanserin; MEI Begins Phase II Trial of Pracinostat Below is a look at some of the headlines for companies that made news in the healthcare sector on June 18, 2013. » Read More Healthcare Review: ACADIA Pharmaceuticals, Chembio Diagnostics, STAAR Surgical, GenMark Diagnostics, Arena Pharmaceuticals Stocks extended gains as the Federal Reserve began a two-day policy meeting to discuss whether the economy has grown strong enough for the central bank to draw down its stimulus measures. » Read More MannKind Completes Phase 3 Clinical Study of AFREZZA; Rexahn Wins US Patent for Novel Anti-Cancer Compounds Below is a look at some of the headlines for companies that made news in the healthcare sector on June 17, 2013. » Read More Healthcare Review: Medivation, Atossa Genetics Inc, MannKind Corporation, Amgen, Amicus Therapeutics U.S. stocks rebounded on Monday, climbing 1 percent and recovering last week's losses, as investors speculated the Federal Reserve will reaffirm its policies of supporting the economic recovery later this week. » Read More BioMarin Initiates Phase 3 Trial for PEG-PAL; Elan To Proceed with Formal Sale Process Below is a look at some of the headlines for companies that made news in the healthcare sector on June 13, 2013. » Read More

Next Prev Breaking News Aurigene and Debiopharm Group™ Report Nomination of Development Candidate Debio 0617B in Oncology LAUSANNE, Switzerlandand BANGALO... Read more ViroPharmas Buccolam® (midazolam, munnvann, oppløsning) er nå godkjent og tilgjengelig i Norge for a... OSLO, Norge, June 19, 2013/PRNewswire/ -- ViroP... Read more Avis aux mdias : Des pdiatres se rassemblent pour discuter de sujets d'actualit en sant des enfants EDMONTON, ALBERTA--(Marketwired - 19 juin 2013) -Le 90 econgrès annuel de la Société canadienne d... Read more Media Advisory: Paediatricians Gather to Discuss Hot Topics in Child and Youth Health EDMONTON, ALBERTA--(Marketwired - June 19, 2013) -The Canadian Paediatric Society's 90 thAnnual C... Read more Research and Markets: Global Plasma Market 2013 - Report Research and MarketsLaura Wood, Senior Manager.... Read more Research and Markets: Material and Clinical Trial Requirements of Application and Approval for Impor... Research and MarketsLaura Wood, Senior Manager.... Read more Research and Markets: CRA Training Series: Volume 1 - An Overview of Drug Development 2013 Research and MarketsLaura Wood, Senior Managerp... Read more Research and Markets: Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines Report Research and MarketsLaura Wood, Senior Manager.... Read more Research and Markets: Global Inflammatory Bowel Diseases Pipeline Capsule - 2013 Research and MarketsLaura Wood, Senior Managerp... Read more Safinamide Phase III Study Results Presented at 2013 MDS Meeting MILAN, June 19, 2013/PRNewswire/... Read more VIVUS Posts Investor Presentation Urges Stockholders Not to be Misled by FMC's Distracting Proxy Campaign Vote the GOLD Proxy Ca... Read more Flex Educating SHRM Annual Conference Attendees about the "Buzz" with Health Insurance Exchanges ROSEMONT, Ill., June 19, 2013 (GLOBE NEWSWIRE) Read more AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outc... Read more Protalix BioTherapeutics and Brazil's Ministry of Health Enter Into Supply and Technology Transfer A... CARMIEL, Israel, June 19, 2013 (GLOBE NEWSWIRE) Read more Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock NEW YORK, June 18, 2013/PRNewswi... Read more Ardis Dee Hoven, M.D., Inaugurated as 168th President of AMA SOURCE: American Medical Association Lexington Infectious Disease Specialist's Work With HIV/AID... Read more Vemma(R) Honored as a Five-Time Stevie(R) Award Winner in 2013 American Business Awards(SM) SOURCE: Vemma Nutrition Company Read more AMA Adopts New Policies on Second Day of Voting at Annual Meeting SOURCE: American Medical Association CHICAGO, IL--(Marketwired - June 18, 2013) - The American... Read more

More Articles...

MannKind Completes Phase 3 Clinical Study of AFREZZA; Rexahn Wins US Patent for Novel Anti-Cancer Compounds
Healthcare Review: Medivation, Atossa Genetics Inc, MannKind Corporation, Amgen, Amicus Therapeutics
Short Sellers Flee Questcor on Sentiment Reversal
BioMarin Initiates Phase 3 Trial for PEG-PAL; Elan To Proceed with Formal Sale Process
Healthcare Review: Myriad Genetics, ACADIA Pharmaceuticals, Astex Pharmaceuticals, Cempra Inc, Inovio Pharmaceuticals
FDA Issues Approval for Amgen's Xgeva; XOMA Begins Pilot Trial Evaluating Gevokizumab
Healthcare Review: Elan Corporation, XOMA Corp, Celsion Corporation, Catalyst Pharmaceutical, MannKind Corporation
Northwest Biotherapeutics: Targeting Glioblastoma with Immunotherapy
Incyte Says FDA Updates Prescribing Info for Jakafi; RBC Says Amgen's AMG-386 Will Need to See Increases in Overall Survival Benefits Before FDA Approval
Healthcare Review: Navidea Biopharmaceuticals, Celgene Corporation, Arena Pharmaceuticals, Celsion Corporation, St. Jude Medical
Wednesday's Biotech Catalyst Trade Watch List
Salix's Relistor Could Provide FDA Panel 'Another Meaningful Catalyst'; Biota Initiates Phase 2 Trial of Laninamivir Octanoate
Healthcare Review: Catamaran Corp, Questcor Pharmaceuticals, CIGNA Corporation, Dynavax Technologies, Immunomedics
Clovis / CO-1686 – Value, Derived From Data, Supports The Valuation
OXiGENE Reports Publication of Final FACT Study Data in Journal Thyroid; Immunomedics' 90Y-Epratuzumab Study Shows Improvement of Therapy Results
Healthcare Review: Dynavax Technologies, Apricus Biosciences, ACADIA Pharmaceuticals, Celldex Therapeutics, Avanir Pharmaceuticals
OPKO: More Hidden Value in Partnerships & Equity Investments
Arena Reports on Launch of BELVIQ (lorcaserin HCl) CIV for Chronic Weight Management in Adults; Glaxo's Avandia Wins FDA Victory
Healthcare Review: Rosetta Genomics, Synta Pharmaceuticals, Elan Corporation, Orexigen Therapeutics, Gilead Sciences
FDA panel votes to relax Avandia restrictions
Healthcare Review: Savient Pharmaceuticals, Hemispherx BioPharma, ACADIA Pharmaceuticals, Novavax, Affymax
OPKO Looks Lucrative as Acquired hGH-CTP Moves Into Phase III Trials
Pluristem CEO, Zami Aberman Answers the Tough Questions
Idera Announces Initiation of a Phase 2 Trial of IMO-8400; Avanir Announces Accelerated Development Path for AVP-786
Healthcare Review: TrovaGene Inc, Vanda Pharmaceuticals, Avanir Pharmaceuticals, Neurometrix Inc, Aegerion Pharmaceuticals
Cowen Questions Sales Growth of Biogen Idec’s MS Drug Tecfidera
Pluristem to Receive Clinical-hold Notice From the FDA; FDA Grants Priority Review to Bristol-Myers Squibb and AstraZeneca's Metreleptin
Healthcare Review: MannKind Corporation, StemCells Inc, Pluristem Therapeutics Inc, Rosetta Genomics Ltd, Infinity Pharmaceuticals
Clovis Oncology Skyrockets After ASCO Presentations
Novartis Says Breakthrough Therapy LDK378 Shows Response; Nektar Announces Positive Preclinical Data for NKTR-214
Healthcare Review: TESARO Inc, Nektar Therapeutics, Clovis Oncology Inc, Curis, Synta Pharmaceuticals
Biotech Buyout Speculation Trius Could Be Acquired Very Soon
Affymax Drops on NASDAQ Delisting & Criticism
Biotech Buyout Speculation Trius Could Be Acquired Very Soon
MannKind Closes Phase 3 Study of AFREZZA; Alkermes Issues Positive Results of ALKS 5461
Healthcare Review: Celsion Corporation, Alliance HealthCare Services, Uroplasty, Endo Health Solutions, Arena Pharmaceuticals
4 Top Small Cap Biotech Acquisition Targets
Endo Says FDA Issues CRL on Aveed NDA, Added Trials Not Included; FDA Lifts Clinical Hold on PharmAthene's SparVax

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 799

Login Form

twitter

BioMedReports @BioMedReports

BioMedReports http://t.co/qipcYkZjd7

12h • reply • retweet • favorite

BioMedReports Healthcare Review: ACADIA Pharmaceuticals, Chembio Diagnostics, STAAR Surgical, GenMark Diagnostics, Arena Pha... http://t.co/oQkwRxU8ce

15h • reply • retweet • favorite

BioMedReports Medivation’s Xtandi Threatened by J&J’s New Acquisition: One of the biotech laggards of the year, Medivation (... http://t.co/VwmG4D0XY3

19h • reply • retweet • favorite

Featured Content

Subscriber Only Content

Sector News

Breaking News

Login Form

RSS Subscription